Biological/Vaccine: Placebo clinical trials

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

This study is testing a new treatment called rFVIIa for a serious type of stroke caused by bleeding in the brain. It aims to see if giving this medicine quickly can improve recovery and reduce further bleeding for certain patients.